Genes controlling asymmetric cell divisions during C. elegans development
Project Number2R01NS042213-05A1
Contact PI/Project LeaderGARRIGA, GIAN
Awardee OrganizationUNIVERSITY OF CALIFORNIA BERKELEY
Description
Abstract Text
DESCRIPTION (provided by applicant): A fundamental question in development is how cells are specified. Elucidating mechanisms of cell-type specification is essential to the understanding and eventually treating human diseases, such as cancer, where this process is altered. One mechanism that specifies cell type is Asymmetric Cell Division, where a cell divides to produce two daughter cells that adopt distinct fates. Both intracellular asymmetric molecules and cell signaling appear to polarize neuroblasts, but a connection between the two mechanisms has been lacking. We have found that signaling is essential for certain asymmetric divisions that produce apoptotic cells and neural precursors and have identified molecules that are asymmetrically distributed in these divisions. The overall goal of our research is to understand how both cell intrinsic mechanisms and signaling regulate the fates of the neurons that are generated during these divisions. The proposal has three aims. 1) We propose to determine how the cytohesin GRP-1 regulates asymmetric cell divisions. Our model proposes that GRP-1 functions in V5 to regulate signaling between V5 and asymmetrically dividing neuroblasts, and we will test this idea rigorously for several divisions that require GRP-1 function. We will test the model that PI3K regulates GRP-1 and mediates its effects though ARF-1 and ARF-6. GRP-1's surprising localization to the nucleus raises the interesting possibility that cytohesins may function there, and we will ask whether GRP-1 carries out its functions in the nucleus. Finally, we will pursue RNG-1 and CNT-2, two molecules that may function in the GRP-1 pathway. 2) We propose to determine how Wnts regulate asymmetric divisions of the Q neuroblast, which also require both PIG-1 and GRP-1 function. Our preliminary experiments indicate that three Wnts and two Frizzled receptors are involved in these divisions. We will test the roles of the remaining Wnts and Wnt receptors, characterize the effects of these mutations on the divisions in more detail and test whether Wnt signaling acts in the GRP-1 or PIG-1 pathways. 3) Our analysis of GRP-1 and Wnt signaling indicates that cell signaling regulates asymmetric cell divisions. We will continue our EMS screens and begin RNAi screens to identify molecules that function in these signaling events, as well as molecules that act with HAM-1 and PIG-1.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AdoptedApoptoticCaenorhabditis elegansCell NucleusCell divisionCellsDevelopmentEventFamily suidaeGenesGoalsMalignant NeoplasmsMediatingModelingMutationNervous system structureNeuronsPathway interactionsProcessRNA InterferenceResearchRoleSignal TransductionSpecific qualifier valueSus scrofaTestingcell typedaughter cellgastrin-releasing peptide 1human diseaseinterestneuroblastreceptorresearch study
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
124726725
UEI
GS3YEVSS12N6
Project Start Date
01-September-2001
Project End Date
31-January-2011
Budget Start Date
01-February-2007
Budget End Date
31-January-2008
Project Funding Information for 2007
Total Funding
$257,552
Direct Costs
$175,000
Indirect Costs
$82,552
Year
Funding IC
FY Total Cost by IC
2007
National Institute of Neurological Disorders and Stroke
$257,552
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2R01NS042213-05A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R01NS042213-05A1
Patents
No Patents information available for 2R01NS042213-05A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R01NS042213-05A1
Clinical Studies
No Clinical Studies information available for 2R01NS042213-05A1
News and More
Related News Releases
No news release information available for 2R01NS042213-05A1
History
No Historical information available for 2R01NS042213-05A1
Similar Projects
No Similar Projects information available for 2R01NS042213-05A1